Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy. [electronic resource]
- Transplantation proceedings Feb 2002
- 73-4 p. digital
Adult Aged Antibodies, Viral--therapeutic use Antilymphocyte Serum--therapeutic use Antiviral Agents--therapeutic use Cytomegalovirus--immunology Cytomegalovirus Infections--prevention & control Female Ganciclovir--therapeutic use Humans Immunosuppressive Agents--therapeutic use Kidney Transplantation--immunology Male Middle Aged Retrospective Studies